ESOPHAGOGASTRIC ADENOCARCINOMA
Clinical trials for ESOPHAGOGASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGOGASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGOGASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy targets advanced stomach cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new cell therapy for advanced stomach and esophageal cancers that have spread to the abdominal lining. Doctors collect a patient's own immune cells, modify them in a lab to better target cancer cells, and then infuse them directly…
Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for stomach cancer: testing powerful drug duos before surgery
Disease control Recruiting nowThis study is testing whether new combinations of cancer drugs are safe and effective when given before surgery for a specific type of advanced stomach or esophageal cancer. The trial will involve about 36 patients whose cancer has a specific marker called HER2-positive. The goal…
Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC